2024
February 9, 2024
Sanofi at COP28: supporting the decarbonization of healthcare systems
February 9, 2024
Sanofi Global Health Unit Impact fund invests in African healthcare start-ups
February 9, 2024
EMA gives positive opinion to Fexinidazole Winthrop as first oral treatment of sleeping sickness (rhodesiense)
2023
November 14, 2023
Impact brand: First Cardio-Metabolic medicines delivered to Djibouti and global NGOs
November 14, 2023
Sanofi inaugurates a new photovoltaic park in France
November 14, 2023
Progress on the partnership with Ghana’s Ministry of Health to improve access to diabetes care
September 21, 2023
Inclusivity at the forefront of our clinical trials
September 21, 2023
Sanofi CHC North America earns B Corp Certification
September 21, 2023
Pilot take-back programs for insulin pens launched in 2 European countries
June 1, 2023
Sanofi partnering with the Ghana Ministry of Health to improve affordable access to diabetes care
June 1, 2023
Sanofi capping its insulin to a $35 out-of-pocket costs in the U.S.
June 1, 2023
Net Zero towards 2045
March 9, 2023
Sanofi Global Health Unit impact fund first investment in Swipe RX
February 6, 2023
Transform the treatment of sleeping sickness
February 6, 2023
